Barclays
ELVN icon

Barclays’s Enliven Therapeutics ELVN Stock Holding History

Barclays’s Portfolio ELVN Stock Details ELVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$464K Sell
11,830
-58,045
-83% -$1.61M ﹤0.01% 3233
2025
Q4 		$1.08M Sell
69,875
-814
-1% -$16.2K ﹤0.01% 3380
2025
Q3 		$1.45M Sell
70,689
-2,095
-3% -$42.2K ﹤0.01% 3124
2025
Q2 		$1.46M Buy
72,784
+22,427
+45% +$425K ﹤0.01% 3086
2025
Q1 		$991K Sell
50,357
-14,206
-22% -$306K ﹤0.01% 3109
2024
Q4 		$1.45M Buy
64,563
+8,346
+15% +$216K ﹤0.01% 3123
2024
Q3 		$1.44M Buy
56,217
+42,012
+296% +$973K ﹤0.01% 3112
2024
Q2 		$332K Sell
14,205
-12,031
-46% -$253K ﹤0.01% 3286
2024
Q1 		$461K Sell
26,236
-15,842
-38% -$243K ﹤0.01% 3641
2023
Q4 		$582K Buy
42,078
+28,449
+209% +$348K ﹤0.01% 3786
2023
Q3 		$186K Sell
13,629
-1,198
-8% -$20.2K ﹤0.01% 3335
2023
Q2 		$303K Buy
14,827
+7,600
+105% +$154K ﹤0.01% 3042
2023
Q1 		$158K Buy
+7,227
New +$147K ﹤0.01% 3928

Other funds holding ELVN

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return